128 related articles for article (PubMed ID: 6124265)
1. Comparison of labetalol with other anti-hypertensive drugs.
Prichard BN; Richards DA
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
[TBL] [Abstract][Full Text] [Related]
2. Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
Rezk M; Emarh M; Masood A; Dawood R; El-Shamy E; Gamal A; Badr H
Hypertens Pregnancy; 2020 Nov; 39(4):393-398. PubMed ID: 32697618
[TBL] [Abstract][Full Text] [Related]
3. Perioperative hypertension management.
Varon J; Marik PE
Vasc Health Risk Manag; 2008; 4(3):615-27. PubMed ID: 18827911
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Intravenous Antihypertensives through Clinical Decision Support in a Large Safety Net System.
Krouss M; Tsega S; Alaiev D; Talledo J; Chandra K; Manchego PA; Zaurova M; Shin D; Garcia M; Cho HJ
Jt Comm J Qual Patient Saf; 2023; 49(6-7):291-296. PubMed ID: 37024423
[TBL] [Abstract][Full Text] [Related]
5. Labetalol-induced hepatitis in a patient with chronic hepatitis B infection.
Marinella MA
J Clin Hypertens (Greenwich); 2002; 4(2):120-1. PubMed ID: 11927791
[TBL] [Abstract][Full Text] [Related]
6. An audit of postoperative haemodynamic stability after intraoperative labetalol administration in non-cardiac surgery patients.
Cairns BB; McNeil MV; Milne AD
J Perioper Pract; 2024 Feb; ():17504589231223011. PubMed ID: 38343016
[TBL] [Abstract][Full Text] [Related]
7. Management of hypertensive crises in the elderly.
Alshami A; Romero C; Avila A; Varon J
J Geriatr Cardiol; 2018 Jul; 15(7):504-512. PubMed ID: 30364798
[TBL] [Abstract][Full Text] [Related]
8. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
MacCarthy EP; Bloomfield SS
Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
[TBL] [Abstract][Full Text] [Related]
9. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
10. Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension.
el-Qarmalawi AM; Morsy AH; al-Fadly A; Obeid A; Hashem M
Int J Gynaecol Obstet; 1995 May; 49(2):125-30. PubMed ID: 7649315
[TBL] [Abstract][Full Text] [Related]
11. Labetalol.
Carter BL
Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
[TBL] [Abstract][Full Text] [Related]
12. Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension.
Ojha U; Ruddaraju S; Sabapathy N; Ravindran V; Worapongsatitaya P; Haq J; Mohammed R; Patel V
Am J Cardiovasc Drugs; 2022 May; 22(3):271-285. PubMed ID: 34878631
[TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of labetalol as antihypertensive agent in dogs.
Zublena F; De Gennaro C; Corletto F
BMC Vet Res; 2020 Jul; 16(1):256. PubMed ID: 32709242
[TBL] [Abstract][Full Text] [Related]
14. Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.
Mann SJ
Curr Cardiol Rep; 2015 Nov; 17(11):99. PubMed ID: 26370555
[TBL] [Abstract][Full Text] [Related]
15. A simplified mechanistic algorithm for treating resistant hypertension: efficacy in a retrospective study.
Mann SJ; Parikh NS
J Clin Hypertens (Greenwich); 2012 Apr; 14(4):191-7. PubMed ID: 22458739
[TBL] [Abstract][Full Text] [Related]
16. Combined alpha/beta-blockade: an underused approach to the treatment of resistant hypertension.
Mann SJ
J Clin Hypertens (Greenwich); 2007 Sep; 9(9):663-6. PubMed ID: 17786066
[No Abstract] [Full Text] [Related]
17. Labetalol: the nineteen-eighties.
Robertson JI
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):137S-141S. PubMed ID: 7093098
[No Abstract] [Full Text] [Related]
18. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
19. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
Frishman WH
Cardiovasc Drugs Ther; 1988 Sep; 2(3):343-53. PubMed ID: 2908732
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
